TP53 and neoplasm: Finally, subcutaneous or orthotopic implantation of PDAC cells in MMP9-deficient mice diminished tumor take, tumor growth, angiogenesis and metastasis [83,89] but tumor progression and metastasis increased in MMP9-deficient mice on the Kras(G12D)/Tp53 background [90].